XCUR
XCUR
NASDAQ · Biotechnology

Exicure Inc

$4.10
-0.15 (-3.63%)
As of Apr 1, 3:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.77M
Net Income
-34,356,212
Gross Margin
Profit Margin
-1,940.2%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.5% 43.5% 43.5%
Operating Margin -2,365.0% 21.6% 22.5% 19.1%
Profit Margin -1,940.2% 16.1% 17.9% 19.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.77M 10.40M 9.97M 8.09M
Gross Profit 4.53M 4.34M 3.52M
Operating Income -41,877,220 2.24M 2.25M 1.55M
Net Income -34,356,212 1.68M 1.79M 1.56M
Gross Margin 43.5% 43.5% 43.5%
Operating Margin -2,365.0% 21.6% 22.5% 19.1%
Profit Margin -1,940.2% 16.1% 17.9% 19.2%
Rev Growth +2.0% -1.5% -6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 7.74M 7.83M 6.95M
Total Equity 23.39M 23.00M 25.54M
D/E Ratio 0.33 0.34 0.27
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -34,210,763 3.32M 3.17M 2.28M
Free Cash Flow 838.7K 1.16M 856.1K